newsfilter
← Latest News
GlobeNewswire·

BioVie Completes Enrollment in Phase 2 SUNRISE-PD Trial in Early Parkinson's Disease

- Patient-centric trial aiming to evaluate whether bezisterim can help delay disease progression reaches enrollment milestone - - Topline Results from the SUNRISE-PD Trial Expected in 1H 2026 - CARSON CITY, Nev., Jan.